20-13117633-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_018327.4(SPTLC3):āc.1060T>Cā(p.Phe354Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000614 in 1,613,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018327.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTLC3 | NM_018327.4 | c.1060T>C | p.Phe354Leu | missense_variant | 8/12 | ENST00000399002.7 | NP_060797.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTLC3 | ENST00000399002.7 | c.1060T>C | p.Phe354Leu | missense_variant | 8/12 | 1 | NM_018327.4 | ENSP00000381968 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151774Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000643 AC: 16AN: 248854Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134976
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461750Hom.: 0 Cov.: 31 AF XY: 0.0000509 AC XY: 37AN XY: 727174
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151774Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74100
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.1060T>C (p.F354L) alteration is located in exon 8 (coding exon 8) of the SPTLC3 gene. This alteration results from a T to C substitution at nucleotide position 1060, causing the phenylalanine (F) at amino acid position 354 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at